The Verisae solution is the first web-enabled site and asset management software created to meet the unique needs of multi-site owners. We offer a powerful suite of web-based process management solutions for facilities, the assets in those facilities, and the people who manage them.

BlazeMeter offers a cross-enterprise test automation framework for the entire technical team (developers, devops, ops and QA) throughout the product development lifecycle. Run continuous or on demand testing for APIs, mobile apps and websites. Run from the cloud, on-premise or as a hybrid solution. Use with JMeter & Selenium WebDriver & integrate with your existing CI, CD & APM tools.

AppLovin turns mobile into the medium of choice for brands by using data gathered across screens to deliver dynamic mobile ads for consumers.

Baynote software provides personalized shopping experiences that help drive conversions. Let us help improve your customers' experiences today.

Krux Digital helps anyone with a website safeguard, manage, and make responsible use of consumer data signatures across devices, sources, and formats. Krux arms web publishers with the technology and know-how to compete in a data game currently dominated by advertisers and market middlemen.

Brands can reach shoppers, drive traffic, and attribute sales through this performance marketing platform spanning the largest retail and travel sites.

Largest marketplace that makes YouTube, Twitter, Instagram and Vine influencer marketing easy for advertisers, brands and influencers.

Meshify brings devices online. Tank monitoring, energy management, electronic pest control, and more.

Tute Genomics is opening a new door for precision medicine by enabling researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment.

We help our clients build the great companies of tomorrow by providing them with the world's meaningful business information and resources to understand it.

WorkLife automates meeting best practices — setting and sharing agendas, driving towards decisions and action items, circulating meeting summaries — to help your team get more done faster.

A global services provider, helping companies power their business with mobile, social and cloud technology from salesforce.com, Google, Workday and CSOD

Eyefluence synchronizes biology and technology to deliver eye-interaction user interfaces for the HMD industry (head-mounted displays).

StarMobile was established in 2012 and is based at Technology Square in the Midtown area of Atlanta, Georgia, USA, a technology community that is recognized as a national, if not global, locus for mobility technology.

Revolutionizing cardiac device data management

Catchpoint delivers world-class Web Performance Monitoring for all Internet services: Website, Mobile, App, Ads, API, DNS, CDN, Streaming, Cloud, & more

UrbanSitter is an online service which uses Facebook to connect parents with babysitters.

BlackLine (NASDAQ: BL) is the worlds most trusted solution for Finance Controls & Automation for delivering powerful real-time automation to accounting & finance teams.

Cloudian, A leading US s3 cloud Storage Company which offers object storage software, s3 object storage solutions. We are providing massive scalable cloud storage solutions

Wochit is a revolution in short form video. The cloud based video creation platform enables brands and storytellers to instantly react to any story and economically scale branded, studio-quality video production.

The largest Military & Government exclusive ecommerce site offering discounts up to 50% off current season goods from 250+ top lifestyle and tactical brands.

AdAdapted is the first mobile advertising company focused on integrating CPG brands into the apps that drive consumers’ in-store purchase decisions.

Super League Gaming is the world's first recreational video game league in a cool movie theater. Every week gamers bring a laptop and friends to a nearby Regal, AMC, Cinemark or iPic. Super League creates the best entertaining gameplay experience - ever.

Revolutionizing cardiac device data management

Delta ID provides the most convenient authentication solution to secure your digital ID.

FireScope offers complete IT monitoring, from user experiences to applications, servers, storage and network, with the ability to correlate individual events to their larger impact on services and users.

StreamLink Software began as nonprofit executives saw a need for solutions to common management issues. When it became clear there was gap in quality, affordable products, StreamLink Software was formed to develop them.

You’re not just getting great software. We’ve sat in your seat and wished there was a better way, so we built it. We provide a multi-asset class portfolio management and reporting system.

Retention Science is the leader in Retention Marketing. Our team consists of passionate data scientists, statisticians, engineers and marketing experts. We bring our expertise together to create the most effective customer retention solutions that enable businesses to maximize customer lifetime value.

As we close out 2019 and focus our attention to the forecasts of 2020, here is a sneak peek into what's IT leaders have on their roadmaps for 2020.

Keep on reading: 5 strategic priorities for CIOs in 2020

EBS is one of AWS’s primary storage services and is supported by a wide variety of functionalities, including built-in snapshot backups. We're sharing how you can use snapshots to maximize the value of your EBS services.

Keep on reading: 5 Ways EBS Snapshots Can Make Your Life Easier

Fyusion's technology may not scream “artificial intelligence” to the general public, but it does provide an intuitive, lifelike experience for consumers. It's their consumer-friendly technology that makes Co-Founder, Pantelis Kalogiros's view on purchasing behaviour worth listening to - especially for those integrating AI into their commerce businesses.  

Keep on reading: M.R. Asks 3 Questions: Pantelis Kalogiros, Co-Founder & VP, Fyusion

Whether you're a new or established user of Amazon's EBS here are seven functions you may not know about that can be used to optimize your system and ROI.

Keep on reading: 7 Little-Known Amazon EBS Features You Should Be Using

COO, Chris Luttrell shares her wealth of information about the current state of fraud, what IDology research is revealing about patron's trust and the forecasted impact of recent privacy legislation on consumers and businesses.

Keep on reading: Quick Answers to Quick Questions: In Conversation with Chris Luttrell, COO, IDology

For businesses serving the hospitality sector, growth relies on implementing and capitalizing modernized systems to improve processes and increase guest satisfaction. These are the four most important strategies to achieve this goal in 2020.

Keep on reading: 4 Tech Trends for the New Hotel Age

CEO at Datrium, Tim Page has a sharpness for how enterprises can protect and prepare their data and operations for disaster recovery - especially when it comes to ransomware.

Keep on reading: M.R. Asks 3 Questions: Tim Page, CEO, Datrium

With 34 years of programming experience in various organizations, Cal shares what he's observed of leaders who are looking to be reinvigorated, what to do when job-inspiration is lost and taking an educated leap of faith.

Keep on reading: Quick Answers to Quick Questions: In Conversation with Cal Evans, Senior Consultant, E.I.C.C., Inc.

At the annual invite-only 2020 Enterprise Retreat in Half Moon Bay, CA, 100 enterprise leaders gathered in a social-media free environment, to network, discuss hot topics and dive into provocative, insightful off-the-record 'State of the Union' presentations. This report details their findings.

Keep on reading: The Enterprise 2020 Report: Software CEO Briefing

Additional donations of chloroquine sent to governments in numerous other countries / Various clinical and preclinical studies investigate the efficacy and adverse effects in COVID-19 infections / Bayer plans considerable expansion of production capacities in the event that the efficacy of chloroquine is proven for COVID-19

Investigation of combination therapies including Bayer’s chloroquine and interferon beta-1b to foster much needed solutions for patients in fight against coronavirus pandemic / Bayer Canada to make CAD 1.5 million (approximately 1 million euros) financial commitment and to supply products in support of the research / Plans to include more than 60 contributing research locations involving 6.000 patients

Employee safety and business continuity are top priorities / Wide-ranging humanitarian and social engagement / Group sales increase by 6.0 percent (Fx & portfolio adj.) to 12.845 billion euros / EBITDA before special items up by 10.2 percent to 4.391 billion euros / All divisions report higher sales and earnings – strong demand at Consumer Health / Net income advances by 20.0 percent to 1.489 billion euros / Core earnings per share increase by 9.9 percent to 2.67 euros / Outlook for 2020: impact of COVID-19 not yet reliably quantifiable

Coronavirus crisis: Employee safety at the top of the agenda / First DAX company to hold virtual stockholders’ meeting / Strategic and operational targets attained in 2019 / Dividend of 2.80 euros per share proposed / Good start to fiscal 2020 / Winkeljohann to succeed Wenning as Supervisory Board Chairman

Pharmacists will be allowed to give out medication to patients who have already been receiving it

Pharmacists are to be allowed to hand out a range of super-strength medicines, including the heroin substitute methadone, without prescription during the Covid-19 crisis, under emergency measures that official drug policy advisers have warned could trigger a spike in drug misuse.

The Advisory Council for Misuse of Drugs (ACMD), which makes recommendations to the government on the control of dangerous drugs, was asked by the home secretary to consider the risks of lifting restrictions on certain substances controlled under the Misuse of Drugs Act.

Two companies jointly have capacity to manufacture hundreds of millions of doses

• Coronavirus – latest updates
• See all our coronavirus coverage

Two of the world’s biggest vaccine companies have joined forces in an “unprecedented” collaboration to develop a Covid-19 vaccine.

GlaxoSmithKline and Sanofi, which combined have the largest vaccine manufacturing capability in the world, are working together on a hi-tech vaccine they say could be in human trials within months.

What is Covid-19?

Pharmaceutical giants will bury treatments in a thicket of patents, making them unaffordable to the world’s poorest

• Coronavirus – latest updates
• See all our coronavirus coverage

How will the Covid-19 pandemic end? According to conventional wisdom, the crisis may ease in a few months, when some of the antiviral medicines on trial succeed. In a few years’ time, when a vaccine becomes available, we may eradicate the virus altogether.

Yet it’s unlikely that this is how the pandemic will actually play out. Although there is every indication that treatments for coronavirus may soon emerge, the mere fact of their existence is no guarantee that people will be able to access them. In fact, Covid-19 is more likely to end in the same way that every pandemic ends: treatments and vaccines will be buried in a thicket of patents – and pharmaceutical companies will ultimately make the decisions about who lives and who dies.

Related: The race to find a coronavirus treatment has one major obstacle: big pharma | Ara Darzi

Stock index up more than 3% in early trading on the back of hopes for remdesivir treatment

Optimism about a potential treatment for Covid-19 gave a shot in the arm to stock markets around the world, amid claims that a drug called remdesivir has spurred rapid recovery in 113 patients.

A University of Chicago hospital participating in a study of the antiviral medication, made by US firm Gilead Sciences, found that nearly all patients suffering severe fever and respiratory symptoms were discharged within a week. A report of the study, issued by specialist healthcare publication Stat News shortly after Wall Street closed on Thursday night, spurred hopes among investors that lockdowns around the world could soon be eased.

Pharmaceutical company says it can produce tests in the high tens of millions by June

• Coronavirus – latest updates
• See all our coronavirus coverage

The pharmaceutical giant Roche has devised a new coronavirus antibody test, which it is aiming to launch in the UK next month.

Antibody testing, which has already been utilised in Germany, South Korea and Finland, is seen as a way for countries to exit lockdown by showing who has already had Covid-19 and could therefore have a degree of immunity.

Related: Antibody tests aren't perfect, but they may be Britain's way out of the lockdown | Eleanor Riley

Government bodies, industry and charities to collaborate in research efforts

• Coronavirus – latest updates
• See all our coronavirus coverage
• Coronavirus vaccine – when will we have one?

The government has announced a new vaccines taskforce to help the development of a vaccine for Covid-19 and ensure its rapid production and rollout if one arrives.

The business secretary, Alok Sharma, also gave details of cash grants for work into both vaccines and potential treatments. Among the projects receiving cash is one led by Public Health England (PHE), which hopes to develop an antibody drug, something that has the potential to work as both a prophylactic and a treatment for those infected.

Related: The hunt for a coronavirus vaccine

Hydroxychloroquine, also known by its brand name, Plaquenil, is a drug used to treat malaria. It is a less toxic version of chloroquine, another malaria drug, which itself is related to quinine, an ingredient in tonic water.

Patients were used as guinea pigs but denied access to resulting therapies. This time, Big Pharma must be held to account

• Coronavirus – latest updates
• See all our coronavirus coverage

The year I turned 11, my uncle Josiah Ssesanga was admitted to a hospital in Uganda with meningitis. It was 1994, and he was HIV positive. Between him and death stood a tattered post-civil war health system.

Treatments for HIV and Aids existed in other parts of the world, but in Uganda they were mostly limited to those used in clinical trials. For my uncle’s particular infection – cryptococcal meningitis – there was a drug called Fluconazole. But he didn’t know it existed; regardless, he wouldn’t have been able to afford it. and even among patients who took it, only 12% survived beyond six months.

Related: Macron calls for clinical trials of controversial coronavirus 'cure'

Related: Fear, bigotry and misinformation – this reminds me of the 1980s Aids pandemic | Edmund White